“…Although Ru(II) and Rh(III) metallointercalators have been widely studied, only a few reports of related compounds with a central Ir(III) ion have previously appeared. [5 -7] These include [Ir(ppy) 2 (dppzR)] 3+ (dppzR = 7-ethyl acetate-dipyrido[3,2-a:2 ,3 -c]phenazine), which has been employed to follow electron transfer in DNA, [5] DNA intercalators of {(η 5 -C 5 Me 5 )Ir[(NMe 2 ) 2 CS](N-N)} (CF 3 SO 3 ) 2 (N-N = dppz and dppn, where dppn = benzo[i]dipyrido[3,2-a:2 ,3 -c]phenazine), [6] and luminescent dipyridoquinoxaline and dipyridophenazine complexes of the type [Ir(ppy) 2 (N-N)](PF 6 ) (N-N = dpq, dppz and dppn, where dpq = 2-N-butylamidodipyrido[3,2-f :2 ,3 -h]quinoxaline). [7] All the studies revealed that molecular modification of DNA binders would lead to subtle or substantial changes in the binding modes, location and affinities, providing the opportunity to explore various valuable conformation-or site-specific DNA probes and anticancer drugs.…”